PF-06648671?is a novel, brain-penetrable, and orally active gamma-secretase modulator (GSM). PF-06648671 reduces Abeta42 and Abeta40, with concomitant increases in Abeta37 and Abeta38 in vitro. PF-06648671 is used for the study of Alzheimers disease[1].
Molecular Weight:
538.92
Purity:
98.12
CAS Number:
[1587727-31-8]
Formula:
C25H23ClF4N4O3
Target:
gamma-secretase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted